002294.SZ
信立泰
SZSE · Healthcare · C 制造业 · CN
CNY 31.62
−3.24%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
31.0x
Market Cap
CNY 35.25B
MomentumView details →
1D Return
−3.24%
YTD Return
−36.59%
RSI (14)
37.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
31.0x
Market Cap
CNY 35.25B
RSI (14)
37.9
MomentumView details →
1D Return
−3.24%
YTD Return
−36.59%
Similar companies
Latest newsMore news →
Shenzhen Salubris Pharmaceuticals updated and resubmitted its H-share listing application to the Hong Kong Stock Exchange on September 3, 2026, for a proposed issuance of overseas listed shares (H shares) and main board listing.2d agoShenzhen Salubris Pharmaceuticals reported a net profit of 387.1 million yuan for the first half of 2026.12d ago